SSY Group Limited (HKG:2005)

Market Cap	10.16B
Revenue (ttm)	5.77B
Net Income (ttm)	1.06B
Shares Out	2.95B
EPS (ttm)	0.36
PE Ratio	9.61
Forward PE	8.70
Dividend	0.18 (5.09%)
Ex-Dividend Date	May 20, 2025

Volume	11,058,000
Average Volume	7,182,176
Open	3.410
Previous Close	3.440
Day's Range	3.310 - 3.430
52-Week Range	3.030 - 5.060
Beta	0.60
RSI	51.87
Earnings Date	Mar 28, 2025

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk ph...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,640
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.